PNC Financial Services Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-273
| Closed | -$5K | – | 4163 |
|
2020
Q2 | $5K | Sell |
273
-100
| -27% | -$1.83K | ﹤0.01% | 3658 |
|
2020
Q1 | $3K | Buy |
373
+259
| +227% | +$2.08K | ﹤0.01% | 3709 |
|
2019
Q4 | $3K | Sell |
114
-196
| -63% | -$5.16K | ﹤0.01% | 3758 |
|
2019
Q3 | $8K | Buy |
310
+73
| +31% | +$1.88K | ﹤0.01% | 3651 |
|
2019
Q2 | $6K | Buy |
237
+101
| +74% | +$2.56K | ﹤0.01% | 3721 |
|
2019
Q1 | $4K | Hold |
136
| – | – | ﹤0.01% | 3808 |
|
2018
Q4 | $2K | Sell |
136
-393
| -74% | -$5.78K | ﹤0.01% | 3905 |
|
2018
Q3 | $15K | Hold |
529
| – | – | ﹤0.01% | 3549 |
|
2018
Q2 | $20K | Sell |
529
-111
| -17% | -$4.2K | ﹤0.01% | 3454 |
|
2018
Q1 | $21K | Buy |
640
+115
| +22% | +$3.77K | ﹤0.01% | 3429 |
|
2017
Q4 | $26K | Buy |
525
+18
| +4% | +$891 | ﹤0.01% | 3286 |
|
2017
Q3 | $28K | Buy |
507
+7
| +1% | +$387 | ﹤0.01% | 3218 |
|
2017
Q2 | $28K | Hold |
500
| – | – | ﹤0.01% | 3190 |
|
2017
Q1 | $20K | Hold |
500
| – | – | ﹤0.01% | 3304 |
|
2016
Q4 | $10K | Hold |
500
| – | – | ﹤0.01% | 3500 |
|
2016
Q3 | $12K | Buy |
500
+100
| +25% | +$2.4K | ﹤0.01% | 3437 |
|
2016
Q2 | $10K | Hold |
400
| – | – | ﹤0.01% | 3573 |
|
2016
Q1 | $8K | Hold |
400
| – | – | ﹤0.01% | 3668 |
|
2015
Q4 | $20K | Buy |
+400
| New | +$20K | ﹤0.01% | 3309 |
|
2015
Q2 | – | Sell |
-75
| Closed | -$3K | – | 4809 |
|
2015
Q1 | $3K | Sell |
75
-777
| -91% | -$31.1K | ﹤0.01% | 4215 |
|
2014
Q4 | $24K | Buy |
+852
| New | +$24K | ﹤0.01% | 3089 |
|
2014
Q2 | – | Sell |
-385
| Closed | -$10K | – | 3941 |
|
2014
Q1 | $10K | Buy |
+385
| New | +$10K | ﹤0.01% | 3075 |
|